Survey on channel assignment algorithms using partially overlapped channels in wireless Mesh network

Autor: Ji-hong WANG, Wen-xiao SHI, Yu-xin LI, Feng JIN, Chun-yue WANG

Publikováno v: Tongxin xuebao, Vol 35, Pp 141-154 (2014)

Capacity degradation caused by co-channel interference was a major challenge faced by wireless Mesh net-work. Partially overlapped channels could be carefully utilized to reduce or even eliminate co-channel interference. The basic concept of partiall

Externí odkaz: https://doaj.org/article/4ac08a799b574431a025e002690a98fe

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The stationary wavelet transform as an efficient reductor of powerline interference for atrial bipolar electrograms in cardiac electrophysiology

Autor: Miguel Martinez-Iniesta, Raúl Alcaraz, Jose J. Rieta, Juan José Ródenas

Publikováno v: RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname

[EN] Objective :The most relevant source of signal contamination in the cardiac electrophysiology (EP) laboratory is the ubiquitous powerline interference (PLI). To reduce this perturbation, algorithms including common fixed-bandwidth and adaptive-no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf69fa1738b1f846e972807e7159fa84

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Autor: Juan Buades, Hartmut Schmidt, Akshay Vaishnaw, Josep M. Campistol, David Adams, Jean Pouget, Jared Gollob, Brian Bettencourt, Ole B. Suhr, Isabel Conceição, Teresa Coelho, John L. Berk, Márcia Waddington-Cruz

Publikováno v: Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, BioMed Central, 2015, 10 (109 ), ⟨10.1186/s13023-015-0326-6⟩
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

Background: Transthyretin-mediated amyloidosis is an inherited, progressively debilitating disease caused by mutations in the transthyretin gene. This study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d843bffbb5a94fb26b80776a45cbe3cb
http://europepmc.org/articles/PMC4559363

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.